Picture of Camurus AB logo

CAMX — Camurus AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Camurus Submits New Drug Application To FDA

Dec 21 (Reuters) - Camurus AB  CAMX.ST :
    * CAMURUS SUBMITS NEW DRUG APPLICATION TO THE US FDA FOR
OCLAIZ™
FOR TREATMENT OF ACROMEGALY

Source text for Eikon:  ID:nWkr9DqJzr 
Further company coverage:  CAMX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Camurus AB

See all news